ClinicalTrials.gg
RecruitingNCT07607782BEGIN IIUpdated Nov 6, 2026

Effect of a Brief Daily Digital Meditation on Well-Being in US Young Adults (BEGIN II)

An interventional study of Miracle of Mind meditation and Neutral audio learning task in Mental Health and General Well-being, sponsored by Beth Israel Deaconess Medical Center. Recruiting at 1 site in United States. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Beth Israel Deaconess Medical Center · Not applicable, Interventional, and Prevention

Updated Nov 6, 2026Now RecruitingFirst site in United States+2 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
354
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

This study is testing whether a short, daily, app-based meditation can help young adults feel better in their everyday lives.

Adults aged 18-40 years who live in the United States and have not meditated regularly (defined as more than four times per week at any point in their lives) are invited to participate.

Participants will be randomly assigned to one of three groups for 4 weeks:

  1. Intervention group: Participants will complete a 7-minute Miracle of Mind meditation each day using a mobile app.
  2. Active comparator group: Participants will listen to a neutral 7-minute audio lesson each day.
  3. Control group: Participants will continue their usual daily routine without adding anything new.

All participants will complete brief online surveys at the start of the study and several times during the 4-week study period. Surveys will ask about mood, stress, anxiety, overall well-being, and mindfulness.

Participants who already wear a smartwatch, such as a Fitbit or Apple Watch, may choose to share heart rate and related data so that researchers can examine whether meditation may also affect physical signs of stress.

Investigators will compare changes over time among the three groups to determine whether the daily 7-minute meditation helps young adults feel better, experience less stress, and become more emotionally resilient.

02

Conditions studied

  • Mental Health and General Well-being

Keywords

  • Digital meditation
  • App-based guided meditation
  • Miracle of Mind meditation
  • Young adults mental health
  • Stress and anxiety reduction
  • Emotional well-being
  • Mindfulness
  • Randomized controlled trial
  • Active and passive control groups
  • Well-being questionnaires
  • Physiological stress indicator
03

In context

Psychological Well-Being

2,193 studies on the registry are indexed under Psychological Well-Being; 728 are open to participants now.

This study's planned enrollment of 354 is above the median of 110 across 1,796 interventional studies indexed under Psychological Well-Being.

Browse Psychological Well-Being studies →

Lead sponsor

Beth Israel Deaconess Medical Center is the lead sponsor of 568 studies on the registry; 80 are open to participants now.

Of its 76 completed or terminated interventional studies of FDA-regulated products, 62 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals between the ages of 18-40 years
  • Currently residing in the USA
  • Individuals who are English speaking
  • Willing and able to download an application on iOS/Android

Exclusion criteria

Exclusion Criteria:

  • Individuals who are non-English speaking
  • Unable to access an iOS/Android smartphone
  • Individuals who regularly practice any form of meditation >4 times per week
  • Individuals scoring 9-12 on the PHQ-4, or ≥3 on either the PHQ-2 or GAD-2 subscale
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
354 participants (estimated)

Study arms

  • Experimental
    Intervention arm: Daily Miracle of Mind meditation

    Participants in this group will use a study app to do a 7-minute Miracle of Mind guided meditation once a day for 4 weeks. The meditation is voice-guided, done while seated, and uses simple breathing techniques. No prior meditation experience is required.

    Behavioral: Miracle of Mind meditation

  • Active comparator
    Active control arm: Daily neutral audio learning

    Participants in this group will use the same study app to listen to a neutral 7-minute audio lesson once a day for 4 weeks. The lessons cover general educational topics and are designed not to be emotional, inspirational, or related to psychology.

    Behavioral: Neutral audio learning task

  • No intervention
    Passive control arm: Usual routine

    Participants in this group will not receive any new activity through the app and will continue their usual daily routine for 4 weeks. They will complete the same study surveys as the other groups but will not be asked to meditate or listen to audio lessons.

Interventions

  • BehavioralMiracle of Mind meditation

    Miracle of Mind is a 7-minute meditation that incorporates breath and awareness to enhance mental health and clarity. The practice involves voice-guided seated meditation with simple breathing techniques. This is a simple, safe intervention that does not require any previous meditation experience.

  • BehavioralNeutral audio learning task

    Active control participants are asked to listen to an approximately 7-minute neutral audio learning task daily in the 3Cs app for the duration of the study. A total of 28 audio learning tasks were sourced from the SDG Academy and Harvard University YouTube and SoundCloud content were screened prior to inclusion.

06

What researchers measure

Primary outcomes

  1. Well-being

    To assess whether a 7-minute digital meditation practiced daily for 4 weeks improves mental well-being, as measured by the World Health Organization-Five Well-Being Index (WHO-5). The WHO-5 total raw score ranges from 0 to 25 where higher scores indicate better mental well-being.

    Time frame: "Baseline, Week 2 and Week 4"

Secondary outcomes

  1. Mindfulness

    To assess whether the 7-minute digital meditation practiced daily for 4 weeks improves mindfulness, as measured by the Mindful Attention Awareness Scale (MAAS). The MAAS mean score ranges from 1 to 6; higher scores indicate greater dispositional mindfulness and attention to present-moment experiences.

    Time frame: "Baseline and 4 weeks"

  2. Overall health

    To assess whether the 7-minute digital meditation practiced daily for 4 weeks improves overall health, as measured by the Whole Person Health Index (WPHI). The WPHI is a 9-item self-reported measure where total scores range from 9 to 45. Higher scores indicate better overall self-reported whole-person health.

    Time frame: "Baseline, Week 2 and Week 4"

  3. Stress

    To assess whether the 7-minute digital meditation practiced daily for 4 weeks reduces psychological distress, as measured by the Schwartz Outcome Scale-10 (SOS-10). The SOS-10 total score ranges from 0 to 60. Higher scores indicate better psychological well-being and functioning, and lower levels of psychological distress.

    Time frame: "Baseline, Week 1, Week 2, Week 3 and Week 4"

  4. Anxiety

    To assess whether the 7-minute digital meditation practiced daily for 4 weeks reduces anxiety, as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety Short Form 8a. The PROMIS Anxiety Short Form 8a includes 8 items, each scored from 1 to 5. The summed raw score ranges from 8 to 40, with higher scores indicating greater anxiety symptoms and a worse outcome.

    Time frame: "Baseline, Week 1, Week 2, Week 3 and Week 4"

  5. Positive and Negative Affect

    To assess whether the 7-minute digital meditation practiced daily for 4 weeks improves emotional well-being, as measured by the Scale of Positive and Negative Experience (SPANE). The SPANE is a 12-item self-reported measure consisting of two 6-item subscales: Positive Experience (SPANE-P) and Negative Experience (SPANE-N). The SPANE-P score ranges from 6 to 30, with higher scores indicating more frequent positive emotions. The SPANE-N score ranges from 6 to 30, with higher scores indicating more frequent negative emotions and a worse outcome. The SPANE Balance score (SPANE-B) is calculated as SPANE-P minus SPANE-N and ranges from -24 to 24. Higher scores indicate a more favorable balance of positive relative to negative emotional experiences and a better outcome.

    Time frame: "Baseline, Week 1, Week 2, Week 3 and Week 4"

Other outcomes

  1. Heart Rate

    To assess differences between study groups in trajectories of heart rate during the 4-week study period, using heart rate data collected from participants' compatible wearable devices. Heart rate will be expressed in beats per minute (bpm).

    Time frame: From enrollment to Week 4

  2. Heart Rate Variability

    To assess differences between study groups in trajectories of heart rate variability during the 4-week study period, using heart rate variability data collected from participants' compatible wearable devices. Heart rate variability will be reported using the pre-specified device-derived metric and units, such as milliseconds (ms). Higher values generally indicate greater beat-to-beat variability.

    Time frame: From enrollment to Week 4

  3. Breathing Rate

    To assess differences between study groups in trajectories of breathing rate during the 4-week study period, using respiratory-rate data collected from participants' compatible wearable devices. Breathing rate will be expressed in breaths per minute. Higher values indicate a higher breathing rate

    Time frame: From enrollment to Week 4

  4. Step Counts

    To assess differences between study groups in daily physical activity during the 4-week study period, using daily step-count data collected from participants' compatible wearable devices. Step count will be reported as the total number of steps per day. Values range from 0 upward, with higher values indicating more ambulatory physical activity.

    Time frame: From enrollment to Week 4

  5. Sleep

    To assess differences between study groups in sleep time, efficiency and average deep sleep duration during the 4-week study period, using sleep data collected from participants' compatible wearable devices.

    Time frame: From enrollment to Week 4

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Status
Not yet recruiting→Recruiting
changed Nov 6, 2026
Sites
1 site added — first site in United States
Show site
  • Beth Israel Deaconess Medical Centre · Boston, United States
Nov 6, 2026
Start date
Sep 15, 2026→Oct 27, 2026 (actual)
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in United States
    Show site
    • Beth Israel Deaconess Medical Centre · Boston, United States
    Start date Sep 15, 2026→Oct 27, 2026 (now actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07607782
Responsible party
Balachundhar Subramaniam (Associate Professor of Anesthesia, Beth Israel Deaconess Medical Center) — Principal investigator
First posted
May 26, 2026
Start date
Oct 27, 2026
Primary completion
Dec 31, 2028 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Nov 6, 2026

Study contacts

Balachundhar Subramaniam, MD, MPH
Contact
sadhgurucenter_research@bidmc.harvard.edu
617-667-2721
Sepideh Hariri, PhD
Contact
sadhgurucenter_research@bidmc.harvard.edu
617-667-2721
Balachundhar Subramainam, MD, MPH
principal investigator · Beth Israel Deaconess Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion